Posts from ‘March, 2010’

Business and Drug Development Industry Executive, James F. Lynch, PhD, MBA, joins PhytoMedical as President and Chief Executive Officer PRINCETON, N.J.–(HSMN NewsFeed)–PhytoMedical Technologies, Inc. (OTCBB: PYTO ), (FWB: ET6) today announced that Dr….
Biopharmaceuticals, Oncology, Personnel
PhytoMedical Technologies

MILAN–(HSMN NewsFeed)–The Company (MIL:SRN) has announced that it has today received a letter requesting permission to conduct, on an exclusive basis, a due diligence on the Company, under appropriate confidentiality measures on behalf of a consortium co…
Devices, Cardiology, Mergers & Acquisitions
Sorin Group, Ares Life Sciences

SALT LAKE CITY–(HSMN NewsFeed)–BSD Laboratory Corporation (NASDAQ:BSDM ) (Company or BSD) today announced that the Company has filed a 510(k) submission with the U.S. Food and Drug Administration (FDA) for premarket clearance of the Company’s Phase II Micro…
Devices
BSD Clinical, MicroThermX, Microwave Ablation, MTX-180

Products will be introduced by New Canadian Distribution Senior partner MINNEAPOLIS, March 22 (HSMN NewsFeed) — ATS Laboratory, Inc. (Nasdaq:ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced that Health…
Devices, Cardiology, Regulatory
ATS Clinical, ATS Simulus, Annuloplasty

Positive Step Toward the First Pacemaker System Approval in the United States for Use in the MRI Environment MINNEAPOLIS–(HSMN NewsFeed)–Medtronic, Inc. (NYSE:MDT ) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System De…
Devices, Cardiology
Medtronic, Revo MRI, SureScan, pacemaker

TOKYO, March Nineteen (HSMN NewsFeed) — Astellas Pharma Inc. (TSE:4503.to ) today notified OSI Pharmaceuticals Inc. (Nasdaq:OSIP ) that John D. Gilly, Ph.D. and Margaret T. Monaco will replace Jack Kaye and Heidi L. Steiger on the slate of directors Astellas…
Biopharmaceuticals, Mergers & Acquisitions, Personnel
Astellas Pharmaceutical, OSI Pharmaceuticals

CAMBRIDGE, England, March 19, 2010 (HSMN NewsFeed) — Mundipharma announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that product management authorisatio…
Biopharmaceuticals, Oncology, Regulatory
Mundipharma, Levact, bendamustine, non-Hodgkin’s lymphoma, leukemia, myeloma

ALISO VIEJO, CA–(HSMN NewsFeed) - CNS Response, Inc. (OTC.BB:CNSO ) has announced that Governor Tommy Thompson has resigned from its Board of Directors, and has agreed to become Chairman of its Advisory Board. Thompson told that the resignation was fo…
Devices, Neurology, Personalized Medicine, Personnel
CNS Response

WILMINGTON, N.C., March 18, 2010 –(HSMN NewsFeed) — TranS1 Inc. (Nasdaq:TSON ), a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative dis…
Devices, Orthopaedic, Neurosurgery, Personnel
TranS1, AxiaLIF

BRISTOL, TN–(HSMN NewsFeed) - King Pharmaceuticals, Inc. (NYSE:KG ) today announced that its subsidiaries, Alpharma Inc. and Alpharma Pharmaceuticals LLC ("Alpharma"), have finalized a civil settlement with the United States Department of Justic…
Biopharmaceuticals
King Pharmaceuticals, Alpharma, Kadian, morphine